NanoSphere Health Sciences Inc.
NSHSF
$0.0038
-$0.0362-90.50%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.22% | 67.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.78% | 86.07% | |||
| Operating Income | 14.78% | -86.07% | |||
| Income Before Tax | 31.75% | -47.94% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 31.75% | -47.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 31.75% | -47.94% | |||
| EBIT | 14.78% | -86.07% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 30.51% | -47.50% | |||
| Normalized Basic EPS | 32.43% | -48.00% | |||
| EPS Diluted | 30.51% | -47.50% | |||
| Normalized Diluted EPS | 32.43% | -48.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
